NAMS Competitors & Alternatives
Compare NewAmsterdam Pharma Company N.V. Ordinary Shares with similar stocks in the same industry
Biotechnology
NAMS
Main Stock$21.58
Tradestie Score
52
Market Cap
$3.31B
Revenue Growth
-0.8%
Analyst Upside
+131.2%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$24.56
|
$2.44B | - | 58 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$72.08
|
$2.42B | - | 62 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$150.27
|
$2.41B | - | 69 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$36.12
|
$2.40B | - | 62 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$32.20
|
$2.37B | 151.8 | 41 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.31
|
$2.34B | - | 39 | Compare |
More NAMS Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry